UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Selexipag: an oral, selective prostacyclin receptor agonist for the treatment of pulmonary arterial hypertension

The European respiratory journal, 2012-10, Vol.40 (4), p.874-880

2012

Volltextzugriff (PDF)

Sputum handling for rheology

Scientific reports, 2023-05, Vol.13 (1), p.7695-7695, Article 7695

2023

Volltextzugriff (PDF)

Safety of denervation following targeted lung denervation therapy for COPD: AIRFLOW-1 3-year outcomes

Respiratory research, 2021-02, Vol.22 (1), p.62-62, Article 62

2021

Volltextzugriff (PDF)

Severe pulmonary arterial hypertension: treatment options and the bridge to transplantation

European respiratory review, 2014-12, Vol.23 (134), p.488-497

2014

Volltextzugriff (PDF)

Transition from intravenous epoprostenol to selexipag in pulmonary arterial hypertension: a word of caution

The European respiratory journal, 2020-06, Vol.55 (6), p.1902418

2020

Volltextzugriff (PDF)

Emphysema in active farmer's lung disease

PloS one, 2017-06, Vol.12 (6), p.e0178263-e0178263

2017

Volltextzugriff (PDF)

Remote Monitoring for Prediction and Management of Acute Exacerbations in Chronic Obstructive Pulmonary Disease (AECOPD)

Life (Basel, Switzerland), 2022-03, Vol.12 (4), p.499

2022

Volltextzugriff (PDF)

Divergent endothelial function but similar platelet microvesicle responses following eccentric and concentric cycling at a similar aerobic power output

Journal of applied physiology (1985), 2017-04, Vol.122 (4), p.1031-1039

2017

Volltextzugriff (PDF)

Real world evidence in asthma: what to expect beyond randomised controlled trials?

The European respiratory journal, 2024-07, Vol.64 (1), p.2400716

2024

Volltextzugriff (PDF)

Several Nocardia abcessus bronchiolitis in a patient treated with inhaled corticosteroids: a case report

Allergy, asthma, and clinical immunology, 2023-04, Vol.19 (1), p.27-27, Article 27

2023

Volltextzugriff (PDF)

Lung cancer, comorbidities, and medication: the infernal trio

Frontiers in pharmacology, 2024-02, Vol.14, p.1016976-1016976

2024

Volltextzugriff (PDF)

A phase 2 randomized trial to evaluate the impact of a supervised exercise program on cardiotoxicity at 3 months in patients with HER2 overexpressing breast cancer undergoing adjuvant treatment by trastuzumab: design of the CARDAPAC study

BMC cancer, 2017-06, Vol.17 (1), p.425-425, Article 425

2017

Volltextzugriff (PDF)

Clinical and microbiological characteristics of cystic fibrosis adults never colonized by Pseudomonas aeruginosa: Analysis of the French CF registry

PloS one, 2019-01, Vol.14 (1), p.e0210201-e0210201

2019

Volltextzugriff (PDF)

Design for a multicenter, randomized, sham-controlled study to evaluate safety and efficacy after treatment with the Nuvaira® lung denervation system in subjects with chronic obstructive pulmonary disease (AIRFLOW-3)

BMC pulmonary medicine, 2020-02, Vol.20 (1), p.41-41, Article 41

2020

Volltextzugriff (PDF)

Development of a risk prediction model of potentially avoidable readmission for patients hospitalised with community-acquired pneumonia: study protocol and population

BMJ open, 2020-11, Vol.10 (11), p.e040573-e040573

2020

Volltextzugriff (PDF)

Combined measurement of carbon monoxide and nitric oxide lung transfer does not improve the identification of pulmonary hypertension in systemic sclerosis

The European respiratory journal, 2017-10, Vol.50 (4), p.1701008-1701008

2017

Volltextzugriff (PDF)

Is atopy a risk indicator of chronic obstructive pulmonary disease in dairy farmers?

Respiratory research, 2019-06, Vol.20 (1), p.124-124, Article 124

2019

Volltextzugriff (PDF)

Correction to: Safety of denervation following targeted lung denervation therapy for COPD: AIRFLOW-1 3-year outcomes

Respiratory research, 2021-03, Vol.22 (1), p.83-83, Article 83

2021

Volltextzugriff (PDF)

Cardiotoxicity is mitigated after a supervised exercise program in HER2-positive breast cancer undergoing adjuvant trastuzumab

Frontiers in cardiovascular medicine, 2022-09, Vol.9, p.1000846-1000846

2022

Volltextzugriff (PDF)

Smoking habits in French farmers: a cross-sectional study

BMC public health, 2017-02, Vol.17 (1), p.166-166, Article 166

2017

Volltextzugriff (PDF)

Characterization of Pulmonary Arterial Hypertension Patients Walking More Than 450 m in 6 Min at Diagnosis

Chest, 2010-06, Vol.137 (6), p.1297-1303

2010

Volltextzugriff (PDF)

Pulmonary arterial compliance and exercise capacity after balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension

ERJ open research, 2023-03, Vol.9 (2), p.590-2022

2023

Volltextzugriff (PDF)

Cardiac MRI in pulmonary artery hypertension: correlations between morphological and functional parameters and invasive measurements

European radiology, 2010-05, Vol.20 (5), p.1149-1159

2010

Volltextzugriff (PDF)

1 – 25 von 159

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(148)
Mit Volltextzugriff
(145)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(115)
Life Sciences & Biomedicine
(106)
Humans
(79)
Life Sciences
(66)
Female
(51)
Male
(48)
Respiratory System
(45)
Middle Aged
(41)
Adult
(35)
Aged
(29)
Human Health And Pathology
(25)
Pulmonology And Respiratory Tract
(20)
Risk Factors
(20)
Chronic Obstructive Pulmonary Disease
(19)
Patients
(18)
General & Internal Medicine
(17)
Lung Diseases
(17)
Biological And Medical Sciences
(16)
Medical Sciences
(14)
France - Epidemiology
(13)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Selexipag: an oral, selective prostacyclin receptor agonist for the treatment of pulmonary arterial hypertension

Portopulmonary hypertension in the current era of pulmonary hypertension management

Sputum handling for rheology

Safety of denervation following targeted lung denervation therapy for COPD: AIRFLOW-1 3-year outcomes

Severe pulmonary arterial hypertension: treatment options and the bridge to transplantation

Transition from intravenous epoprostenol to selexipag in pulmonary arterial hypertension: a word of caution

Emphysema in active farmer's lung disease

Remote Monitoring for Prediction and Management of Acute Exacerbations in Chronic Obstructive Pulmonary Disease (AECOPD)

Divergent endothelial function but similar platelet microvesicle responses following eccentric and concentric cycling at a similar aerobic power output

Real world evidence in asthma: what to expect beyond randomised controlled trials?

Several Nocardia abcessus bronchiolitis in a patient treated with inhaled corticosteroids: a case report

Lung cancer, comorbidities, and medication: the infernal trio

A phase 2 randomized trial to evaluate the impact of a supervised exercise program on cardiotoxicity at 3 months in patients with HER2 overexpressing breast cancer undergoing adjuvant treatment by trastuzumab: design of the CARDAPAC study

Clinical and microbiological characteristics of cystic fibrosis adults never colonized by Pseudomonas aeruginosa: Analysis of the French CF registry

Design for a multicenter, randomized, sham-controlled study to evaluate safety and efficacy after treatment with the Nuvaira® lung denervation system in subjects with chronic obstructive pulmonary disease (AIRFLOW-3)

Development of a risk prediction model of potentially avoidable readmission for patients hospitalised with community-acquired pneumonia: study protocol and population

Combined measurement of carbon monoxide and nitric oxide lung transfer does not improve the identification of pulmonary hypertension in systemic sclerosis

Is atopy a risk indicator of chronic obstructive pulmonary disease in dairy farmers?

Correction to: Safety of denervation following targeted lung denervation therapy for COPD: AIRFLOW-1 3-year outcomes

Cardiotoxicity is mitigated after a supervised exercise program in HER2-positive breast cancer undergoing adjuvant trastuzumab

Smoking habits in French farmers: a cross-sectional study

Characterization of Pulmonary Arterial Hypertension Patients Walking More Than 450 m in 6 Min at Diagnosis

Pulmonary arterial compliance and exercise capacity after balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension

Cardiac MRI in pulmonary artery hypertension: correlations between morphological and functional parameters and invasive measurements

Independent Association of Urinary F2 -Isoprostanes With Survival in Pulmonary Arterial Hypertension

Suchergebnisse filtern